Literature DB >> 4629078

Biological activity of a partially purified inhibitor of vaccinia virus hemagglutinin.

S C Lau, W A Cassel.   

Abstract

An inhibitor acting against vaccinia virus hemagglutinin, and producing a hemagglutinin-negative virus, was separated from tumorous ascitic plasma. The finding that the partially purified inhibitor was biologically active strengthens the evidence for a specific role of the inhibitor in altering the virus.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4629078      PMCID： PMC422375          DOI： 10.1128/iai.5.3.359-362.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  7 in total

1.  Response of mice to ectromelia and vaccinia viruses.

Authors:  B A BRIODY
Journal:  Bacteriol Rev       Date:  1959-06

2.  A method for determining the sedimentation behavior of enzymes: application to protein mixtures.

Authors:  R G MARTIN; B N AMES
Journal:  J Biol Chem       Date:  1961-05       Impact factor: 5.157

3.  Loss of hemagglutinin on passage of vaccinia virus in L cells.

Authors:  W A CASSEL; B FATER
Journal:  Proc Soc Exp Biol Med       Date:  1959-03

4.  Multiplication of vaccinia virus in the Ehrlich ascites carcinoma.

Authors:  W A CASSEL
Journal:  Virology       Date:  1957-06       Impact factor: 3.616

5.  Nonspecific inhibition of vaccinia hemagglutinin.

Authors:  W A CASSEL; B FATER
Journal:  Science       Date:  1957-08-16       Impact factor: 47.728

6.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

7.  An hypothesis for the mechanism by which an hemagglutinin inhibitor affects vaccinia virus.

Authors:  E Wible; W A Cassel
Journal:  Proc Soc Exp Biol Med       Date:  1970-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.